LuSeed’s DOMEis a first-in-class, minimally invasive device for treating both Bifurcation and Sidewall brain aneurysms simply and safely.  The device is designed for full compatibility with robotic systems.

It is our mission to provide a standard method of care, easily implemented by neuro radiologists at various experience levels, to improve both acute and long-term patient outcomes, mitigate potential complications, and optimize hospitals’ operational and financial burdens.

About LuSeed Vascular

LuSeed Vascular is a pioneering medical technology startup that focuses on advancing neurovascular innovation. Our primary commitment is to create and introduce groundbreaking devices that bring about significant improvements in the treatment outcomes of brain aneurysms.

Introducing LuSeed DOME ™

"One-and-Done" Intrasaccular Device

The company’s flagship product, LuSeed DOME™, is designed to provide neuro interventional physicians with the means to enable better care for their patients by enabling an intuitive, safe delivery and implantation at the target aneurysm, thanks to its unique geometry and characteristics. 

The device provides a first of its kind approach for both Bifurcation and Sidewall Aneurysms, as its positioning in the aneurysm is agnostic to the catheter tip location at the implantation site. 

Moreover, the device does not require dual anticoagulants due to minimized protrusion to parent arteries, mitigating related complications and enhancing long term patient safety.

Broad indication for use

Designed for both bifurcation and sidewall aneurysms.

Five sizes only

Straightforward matching between the device and the aneurysm.

Acute Performance

Tailored for ruptured cases via high mesh density.

Easy to use

Agnostic to catheter tip location and entrance angle at the implantation site.

Optimized safety profile

Proximal marker protrusion-free geometry. No chronic usage of strong blood thinners required.

Short procedural time

Implantation within minutes, reducing Cath-lab use time.

LuSeed Vascular is an innovative MedTech start-up dedicated to the development of cutting-edge solutions for treating neurovascular diseases.

The company’s flagship product, LuSeed DOME™ , is the world’s first “One and Done” aneurysm treatment device tailor-made for both bifurcation and sidewall cases. 

LuSeed DOME™’s  revolutionary braided mesh design enables a quick, easy delivery and positioning within the aneurysm from multiple angles, featuring a gradual, controlled, accurate deployment.

LuSeed DOME™ is designed to minimize protrusion to parent artery, mitigating the chronic need for high-risk Dual Antiplatelets.

Leadership

Amir Arthur

Co-Founder & COO

Nitzan Hirsh

Co-Founder & CEO

Aline Goldstein

QA / RA Director

Gali Vino

VP Clinical

Prof. Vitor Mendes Pereira

Head of Advisory Board, KOL Physician

Moshe Miller

VP R&D

Team

Saar Schvartz@x4

Saar Schvartz

R&D Mechanical Engineer

5

Shlomo Kantor

Mechanical Manufacturing Practical Engineer

4

Evgeni Bykov

R&D Technician

Anastasia Pidiavlonski@x4

Anastasia Pidiavlonski

Logistics and Operations Manager

Avia Paz

QA associate

Board of Directors

Assaf Barnea

Chairman of the Board

Robert Stern

Vice Chairman of the Board

Prof. Elazer Edelman

Assaf Barnea

Chairman of the Board

Robert Stern

Vice Chairman of the Board

Prof. Elazer Edelman

Eli Davidai

Eli Davidai

Ofir Azury

Dr Eran Toledo

Press

Talented, Passionate Medical Device Professional? Contact us!

Contact

Amir Arthur

Co-founder & COO

Vast experienced in strategy building and fundraising for high risk high gain companies.

Amir is a team builder and leader, with a background of several leadership roles in the MedTech industry. Amir holds a Mechanical & Biomedical Engineer, (M.E, Technion, Summa Cum Laude) and has vast experience in percutaneous medical device design, bringing devices from ideation to clinical use. Additionally, Amir brings with him expert experience and deep knowledge of class iii medical devices.

Nitzan Hirsh

Co-founder & CEO

A medical device leader with over twelve years of experience in complex multidisciplinary / class iii devices development.

Nitzan brings with him a proven track record of bringing medical devices from ideation to the market, combining fundraising (both equity and grants), team integration, regulatory and clinical development, IP creation and stakeholder management. Additionally, Nitzan holds a degree in Biomedical Engineering (M.E, Technion, Summa Cum Laude).

Aline@x4

Aline Goldstein

QA / RA Director

Broad experience in Medical Device areas related to quality (establishment and maintenance of QMS, work closely with different functions to assure product quality and continue improvement, leading of QA activities in design project), compliance (implementation of regulatory requirements and support in regulatory audits) and regulations for global registration (support in regulatory submissions including preparation of submission files and communication with regulatory authorities in different territories).

Gali Vino

VP Clinical

 VP of Clinical Affairs at LuSeed Vascular, brings over 19 years of expertise in designing and managing national and international clinical studies across the Pharmaceutical and Medical Device industries, including FDA and EU submissions. Gali has successfully led clinical strategies to achieve product clearance, aligning study goals with business objectives and ensuring cross-functional collaboration.

Prof. Vitor Mendes Pereira

Head of Advisory Board, KOL Physician

A world-renowned endovascular neurosurgeon, and expert in  treating wide neck cerebral  aneurysms and neurovascular  devices advanced testing and  evaluation.

Professor Vitor Mendes-Pereira is Head of Endovascular Research at St. Michaels      Hospital, Tornoto, Canada.

Moshe Miller

VP R&D

A mechanical Engineer with vast experience in the interventional domain. 

Moshe manages the full life cycle of neurovascular medical products from concept to commercial launch. He also brings with him experience in optimizing design and production processes of commercial products.

IMG_2701

Avia Paz

QA associate ​

 Avia holds a bachelor’s degree in Biology and a master’s degree in Medical Sciences from Tel Aviv University with a focus in microbiology and clinical immunology.

Assaf Barnea

Chairman

CEO of Sanara Ventures and Sanara Capital.
Head of the Life Science Advisory Board at The Israel Export Institute.
Highly experienced in healthcare startups, corporate senior management & Venture Capital.

Robert Stern

Vice Chairman of the Board

President Sanibel Capital, a seasoned neurovascular device executive.
Former CEO Vascular Dynamics. Former President and COO of Micrus, Endovascular. Vice-Chair of MIVI Neuro. Chairman of Cardiac-Tec.

Prof. Elazer Edelman,

Professor in Medical Engineering and Science at MIT, Professor of Medicine at Harvard Medical School, and Senior Attending Physician in the coronary care unit at the Brigham and Women’s Hospital in Boston. 

Dr. Edelman directs MIT’s Institute for Medical Engineering and Science (IMES) and Center for Clinical and Translational Research (CCTR) as well as the Harvard-MIT Biomedical Engineering Center (BMEC) – all dedicated to applying the rigors of the physical sciences to elucidate fundamental biologic processes and mechanisms of disease

Eli Davidai

Managing Director at Quadrant Private Equity.

Seasoned, high-profile investor, entrepreneur and executive, invested in numerous tech medical device companies carrying successful M&As / IPOs.

Ofir Azury

Head of Gandyr technology investment group – holds a vast track record in supporting and investing in impact and technology startups, in a variety of domains.

Dr Eran Toledo

PhD in Physics. EVP & CTO, Sanara Ventures & Sanara Capital.
Possesses a strong academic and industry background in Healthtech R&D leadership and business development.